Main menu

The WIPE assay for selection and elimination of HIV-1 provirus in vitro using latency-reversing agents


Persistence of HIV-1 latent reservoir cells during antiretroviral therapy (ART) is a major obstacle for curing HIV-1. Latency-reversing agents (LRAs) are under intensive development to reactivate and eradicate latently infected cells; however, there are a few useful models for evaluating LRA activity in vitro. Here, we established a chronically HIV-1-infected culture system harboring thousands of different HIV-1-infected cell clones with a wide distribution of HIV-1 provirus similar to that observed in vivo. A combination of an LRA and an anti-HIV-1 drug successfully inhibited viral re-emergence after drug discontinuation, demonstrating “experimental cure” in the in vitro model. We demonstrated that the epigenetic environment of the integrated provirus plays a role in determining drug susceptibility. Our widely distributed intact provirus elimination (WIPE) assay will be useful for optimizing therapeutics against HIV-1 latency and provides mechanistic insights into the selection of heterogeneous HIV-1-infected clones during drug treatment.

Authors: Kouki Matsuda, Saiful Islam, Kiyoto Tsuchiya, Benjy Jek Yang Tan, Shin-ichiro Hattori, Hiroo Katsuya, Paola Miyazato, Misaki Matsuo, Nicole S. Delino, Hiroyuki Gatanaga, Shinichi Oka, Kazuhisa Yoshimura, Shuzo Matsushita, Hiroaki Mitsuya, Yorifumi Satou, Kenji Maeda

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

联系我们

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

关于 Oxford Nanopore

Contact us 领导团队 媒体资源和联系方式 投资者 在 Oxford Nanopore 工作 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag